TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/31/23 17:00 | 10/27/23 | AMAM | Ambrx Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Nelson Sonja | CA | O | CFO | S | -125 | 9.82 | 0 | -13 | -9 | 130 | D | ||||||||||||||
1/13/21 16:19 | 1/12/21 | NK | Nantkwest, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Nelson Sonja | CA | O | CFO | S.d | -245 | 15.00 | 0 | -16 | -52 | 15 | D | ||||||||||||||
1/6/21 20:25 | 1/4/21 | NK | Nantkwest, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Nelson Sonja | CA | O | CFO | S.d | -535 | 13.62 | 0 | -39 | -66 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |